Literature DB >> 18814728

Current bioethical issues in parasitology.

D Boury1, E Dei-Cas.   

Abstract

Parasitic diseases constitute the most common infections among the poorest billion people, entailing high mortality rates and leading to long-term infirmities and poverty. Although the setting-up of public health programs implies many ethical consequences, the range of specific questions in parasitology that can be attributed to bioethics remains, to a large extent, unexplored. From the present analysis, it emerged three main issues which characterize ethical stakes in parasitology: accounting the complexity of the field of intervention, putting the principle of justice into practice and managing the changing context of research. From the research angle, medical parasitology-mycology, as other biological disciplines, is undergoing tensions derived from biological reductionism. Thanks to its links with the history and philosophy of the sciences, bioethics can help to clarify them and to explain the growing hold that technologies have over scientific thinking. On the whole, researchers as well as clinicians are called on to assume a specific responsibility, proportional to their competence and their place in the making of scientific, health, economic and social decisions.

Entities:  

Mesh:

Year:  2008        PMID: 18814728     DOI: 10.1051/parasite/2008153489

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


  2 in total

1.  Why the International Workshops on Opportunistic Protists?

Authors:  Edna S Kaneshiro; Eduardo Dei-Cas
Journal:  Eukaryot Cell       Date:  2009-01-23

2.  A charter for biomedical research ethics in a progressive, caring society.

Authors:  Sylvie Vandoolaeghe; Alessandra Blaizot; Danie Boudiguet; Valérie Bougault; Eduardo Dei Cas; Benoît Foligne; Anne Goffard; Hélène Lefranc; Bénédicte Oxombre; Thomas Trentesaux; Bernard Vandenbunder; Isabelle Wolowczuk; Laurence Delhaes
Journal:  Philos Ethics Humanit Med       Date:  2015-11-13       Impact factor: 2.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.